心肺補助システム市場：コンポーネント、疾患タイプ、患者タイプ、用途、最終用途別 - 2025年～2030年の世界予測

心肺補助システム市場は、2024年には26億5,000万米ドルとなり、2025年には28億6,000万米ドル、CAGR 7.82%で成長し、2030年には41億7,000万米ドルに達すると予測されています。

心肺補助システムは、先端医療技術と重要な患者ケアの交差点に位置し、多様な臨床課題に生命維持のためのソリューションを提供します。急速に進化する今日のヘルスケア環境では、洗練された支援メカニズムの必要性がこれまで以上に高まっています。本レポートでは、技術革新、人口動態の変化、進化する臨床需要に牽引される市場力学を詳細に検証します。世界の情勢は、患者の転帰を重視し、先進的な機器を統合することを特徴としており、これらは外科手術、緊急介入、長期的な患者ケアにおいて基本的な役割を担っています。

歴史的には、心肺補助は急性期医療における重症例に限られていましたが、最近の技術的飛躍的進歩により、より日常的な介入にその使用が拡大され、回復率が向上し、重症患者の治療期間全体が短縮されるようになりました。こうした開発は、臨床手法の改善だけでなく、ヘルスケアの優先順位が予防的で包括的なケア提供へと全体的にシフトしていることを反映しています。患者の安全性と有効性を中核とするこの市場は、臨床プロトコルを再定義するための強力な投資と革新的な製品の発売を示し続けており、利害関係者に世界の機会と課題の両方を提供しています。

世界市場力学の変化

心肺補助装置を取り巻く環境は、技術の進歩と患者中心のケアへの新たな取り組みによって、大きな変革期を迎えています。この変革の中心は、デジタルヘルスツールとデータ分析の統合の拡大であり、これらは治療プロトコルを再構築し、クリティカルケア機器の使用を最適化しています。最先端技術の導入により、意思決定プロセスの迅速化、患者モニタリングの高精度化、より個別化された治療レジメンの促進が可能になりました。

このような開発は、ヘルスケア提供者が効率性と転帰の改善という2つの要求を両立させるための、世界の技術革新への意欲が大きな原動力となっています。変革的なシフトはまた、機器の相互運用性が強化され、シームレスなデータフローとケアの継続性が確保されることによって特徴づけられます。さらに、さまざまな地域の規制当局が、次世代支援システムの導入を奨励する先進的な枠組みを導入し始め、市場競争力を高めています。このような技術導入、規制当局の支援、業界の協力の合流は、効率性の向上と患者転帰の改善が卓越性の基準を定義する、心肺医療における新時代の舞台を整えつつあります。

セグメンテーションに関する洞察の深掘り

市場セグメンテーションを調査すると、製品開発、マーケティング戦略、臨床応用を左右する複数の側面を持つ、微妙な状況が明らかになります。コンポーネントの観点から、市場は心肺バイパス装置、体外膜酸素化システム、大動脈内バルーンポンプ、補助人工心臓などの主要製品ラインにわたって幅広く分析されています。各カテゴリーは独自の機能を持ち、急速な技術革新の対象となっており、性能指標や操作信頼性の向上を反映しています。

さらに、成人呼吸窮迫症候群、心原性ショック、肺水腫などの病態を検討する研究により、病型区分はさらに複雑さを増しています。この層別化は、タイムリーな介入が患者の転帰を左右する多様な病態の管理における、これらの支援システムの重要な性質を浮き彫りにしています。患者のタイプを考慮すると、セグメンテーションはさらに深まり、成人、老人、小児に大別されます。老年期の患者は、生理的ニーズが異なるため、特にオーダーメイドのソリューションが必要とされ、機器の機能性をカスタマイズすることがより重要になります。

アプリケーションベースのセグメンテーションは、心臓外科、心臓病学、救急医療、集中治療における使用事例を評価することで、市場をさらに細分化します。様々な医療用途で汎用性と精度を提供するツールを求める医療従事者が増えているためです。最後に、外来手術センター、病院、専門クリニックがそれぞれ異なる調達パターンを持っており、独自の購買行動や臨床要件を通じて需要を誘導していることが、最終用途に基づくレビューによって明らかになりました。この多面的なセグメンテーションの枠組みは、競争が激化するマーケットで戦略的な意思決定を行うために必要な洞察の深さと広さを強調しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的に心肺疾患の発生率が増加
    • 治療選択肢の認知度とアクセス性の向上
    • 心肺補助技術の革新を奨励する政府のインセンティブと資金提供
  • 抑制要因
    • 心肺補助システムの高コスト
  • 機会
    • 精度と効率性の向上における人工知能の導入拡大
    • ポータブルでコンパクトな心肺補助システムへの関心が高まっている
  • 課題
    • 心肺補助装置に対する厳格な規制遵守要件
• 市場セグメンテーション分析
  • コンポーネント：開胸手術における心肺バイパス装置の好ましさの増加
  • 用途：心臓手術における心肺補助システムの適用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 心肺補助システム市場：コンポーネント別

• 人工心肺装置
• 体外式膜型人工肺
• 大動脈内バルーンポンプ
• 補助人工心臓

第7章 心肺補助システム市場：疾患タイプ別

• 成人呼吸窮迫症候群
• 心原性ショック
• 肺水腫

第8章 心肺補助システム市場：患者タイプ別

• 成人患者
• 高齢者
  • 患者
• 小児患者

第9章 心肺補助システム市場：用途別

• 心臓手術
• 心臓病学
• 救急医療
• 集中治療

第10章 心肺補助システム市場：最終用途別

• 外来手術センター
• 病院
• 専門クリニック

第11章 南北アメリカの心肺補助システム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の心肺補助システム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの心肺補助システム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Baxter International
• BIOTRONIK SE & Co KG
• Boston Scientific Corporation
• Concordia Laboratories Inc.
• Edwards Lifesciences Corporation
• Eurosets S.r.l
• Fresenius Medical Care AG
• General Electric Company
• Getinge AB
• Jarvik Heart, Inc.
• Johnson & Johnson
• LivaNova PLC
• Medtronic PLC
• MicroPort Scientific Corporation
• Nipro Corporation
• Penumbra, Inc.
• Senko Medical Instrument Manufacturing Co., Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens AG
• Spectrum Medical
• Stryker Corporation
• SynCardia Systems, LLC
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. CARDIOPULMONARY SUPPORT SYSTEM MARKET MULTI-CURRENCY
• FIGURE 2. CARDIOPULMONARY SUPPORT SYSTEM MARKET MULTI-LANGUAGE
• FIGURE 3. CARDIOPULMONARY SUPPORT SYSTEM MARKET RESEARCH PROCESS
• FIGURE 4. CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. CARDIOPULMONARY SUPPORT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. CARDIOPULMONARY SUPPORT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. CARDIOPULMONARY SUPPORT SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARDIOPULMONARY SUPPORT SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY INTRA-AORTIC BALLOON PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY ADULT RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PULMONARY EDEMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY EMERGENCY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 54. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 82. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 83. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 86. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 88. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 89. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 90. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 92. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 191. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 192. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 193. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 194. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 195. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 215. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 216. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 217. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 218. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 219. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 221. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 222. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 223. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 224. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 225. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 281. CARDIOPULMONARY SUPPORT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 282. CARDIOPULMONARY SUPPORT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

The Cardiopulmonary Support System Market was valued at USD 2.65 billion in 2024 and is projected to grow to USD 2.86 billion in 2025, with a CAGR of 7.82%, reaching USD 4.17 billion by 2030.

The cardiopulmonary support system stands at the intersection of advanced medical technology and critical patient care, offering life-sustaining solutions to a diverse spectrum of clinical challenges. In today's rapidly evolving healthcare environment, the need for sophisticated support mechanisms is more pronounced than ever. This report provides an in-depth examination of the market dynamics, driven by innovation, demographic shifts, and evolving clinical demands. The global landscape is characterized by its emphasis on patient outcomes and the integration of advanced equipment, which together play a fundamental role in surgical procedures, emergency interventions, and long-term patient care.

Historically, cardiopulmonary support has been reserved for severe cases in acute care settings; however, recent technological breakthroughs have expanded its use into more routine interventions, thereby enhancing recovery rates and reducing the overall duration of critical care. These developments not only reflect improved clinical methodologies but also an overarching shift in healthcare priorities towards preventive and comprehensive care delivery. With patient safety and efficacy at its core, the market continues to witness robust investments and innovative product launches that are set to redefine clinical protocols, offering both opportunities and challenges for stakeholders globally.

Transformative Shifts in Global Market Dynamics

The landscape of cardiopulmonary support is undergoing profound transformative shifts, ignited by advancements in technology and a renewed commitment to patient-centric care. At the heart of this transformation is an increased integration of digital health tools and data analytics, which are reshaping treatment protocols and optimizing the use of critical care equipment. The infusion of cutting-edge technologies has enabled faster decision-making processes, higher precision in patient monitoring, and the facilitation of more personalized treatment regimens.

These developments have been largely driven by a global appetite for innovation, as healthcare providers navigate the dual demands of efficiency and improved outcomes. The transformative shifts are also characterized by the enhanced interoperability of devices, ensuring seamless data flow and continuity of care-a crucial component that supports risk management and optimal resource allocation. Adding to the momentum, regulatory bodies across various regions have begun to implement progressive frameworks that encourage the adoption of next-generation support systems, engendering greater market competitiveness. This confluence of technology adoption, regulatory support, and industry collaboration is setting the stage for a new era in cardiopulmonary care, where enhanced efficiency and better patient outcomes define the standard of excellence.

Deep Dive into Segmentation Insights

An exploration of market segmentation reveals a nuanced landscape with multiple dimensions that dictate product development, marketing strategies, and clinical applications. From a component perspective, the market is extensively analyzed across key product lines such as cardiopulmonary bypass equipment, extracorporeal membrane oxygenation systems, intra-aortic balloon pumps, and ventricular assist devices. Each category presents unique capabilities and is subject to rapid innovation, reflecting enhanced performance metrics and operational reliability.

Furthermore, disease type segmentation adds another layer of complexity, with studies examining conditions such as adult respiratory distress syndrome, cardiogenic shock, and pulmonary edema. This stratification highlights the critical nature of these support systems in managing diverse pathological conditions, where timely intervention can determine patient outcomes. The segmentation deepens further when patient type is considered, broadly categorized into adult, geriatric, and pediatric groups. With geriatric patients requiring particularly tailored solutions due to their distinct physiological needs, the focus on customized device functionalities becomes even more vital.

Application-based segmentation further delineates the market by assessing use cases in cardiac surgery, cardiology, emergency medicine, and intensive care. This contributes significant insights into the operational context and clinical efficacy of these systems, as practitioners increasingly demand tools that offer versatility and precision across various medical applications. Finally, a review based on end use reveals that ambulatory surgical centers, hospitals, and specialty clinics each possess distinct procurement patterns, channeling demand through unique purchasing behaviors and clinical requirements. This multifaceted segmentation framework underscores the depth and breadth of insights necessary to drive strategic decision-making in an increasingly competitive marketplace.

Based on Component, market is studied across Cardiopulmonary Bypass Equipment, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps, and Ventricular Assist Devices.

Based on Disease Type, market is studied across Adult Respiratory Distress Syndrome, Cardiogenic Shock, and Pulmonary Edema.

Based on Patient Type, market is studied across Adult Patients, Geriatric, and Pediatric Patients. The Geriatric is further studied across Patients.

Based on Application, market is studied across Cardiac Surgery, Cardiology, Emergency Medicine, and Intensive Care.

Based on End Use, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.

Intraregional Variances and Opportunities

The analysis of key regional insights highlights profound differences in market dynamics among major global territories. In the Americas, the market is propelled by advancements in healthcare infrastructure, strong investment in research and development, and an aggressive adoption of novel medical technologies that enhance clinical outcomes. This region benefits from robust regulatory support and a mature ecosystem that collectively contribute to rapid technological assimilation and widespread acceptance of cardiopulmonary support systems.

In contrast, the combined region of Europe, Middle East & Africa exhibits a unique blend of traditional clinical practices coupled with emergent innovation hubs. Here, deep-rooted clinical expertise exists alongside increasing integration of disruptive technologies, spurring growth in the adoption of hybrid systems that cater to both legacy and modern healthcare environments. This region remains sensitive to policy reforms and demographic shifts, ultimately influencing how technologies are integrated into everyday clinical practice.

The Asia-Pacific region is emerging as a dynamic and rapidly expanding market, driven by large-scale healthcare initiatives, increased capital investments, and an accelerating pace of technology adoption. Rising awareness and improving healthcare accessibility are contributing to a surge in demand for advanced clinical support products. The confluence of these factors positions the Asia-Pacific as a fertile ground for market expansion, where opportunities abound for innovative manufacturers and service providers.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The market is characterized by a competitive landscape populated by a diverse array of industry leaders and emerging players. Pioneering companies like Abbott Laboratories, Baxter International, and BIOTRONIK SE & Co KG have established robust portfolios that combine advanced technology with reliable performance. Likewise, prominent industry titans such as Boston Scientific Corporation and Edwards Lifesciences Corporation continue to drive innovation by investing significantly in research and development.

Other influential organizations including Concordia Laboratories Inc., Eurosets S.r.l, and Fresenius Medical Care AG have also contributed noteworthy advancements, leveraging their deep expertise in engineering and clinical research. Esteemed players like General Electric Company, Getinge AB, and Jarvik Heart, Inc. are well-regarded for their commitment to developing cutting-edge solutions that enhance the safety and efficiency of cardiopulmonary support systems. Strategic initiatives by Johnson & Johnson, LivaNova PLC, and Medtronic PLC have further reinforced the industry's trajectory towards smarter, more connected medical devices.

The competitive fabric is further enriched by organizations such as MicroPort Scientific Corporation, Nipro Corporation, and Penumbra, Inc., whose continuous innovations reflect a commitment to addressing nuanced clinical challenges. This competitive environment is complemented by offerings from Senko Medical Instrument Manufacturing Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Spectrum Medical, Stryker Corporation, SynCardia Systems, LLC, and Terumo Corporation, creating a robust portfolio that serves an extensively diverse patient base. The integration of vast clinical expertise, technological innovation, and strategic global partnerships has given rise to a market that continues to set new benchmarks in precision medicine and critical care solutions.

The report delves into recent significant developments in the Cardiopulmonary Support System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International, BIOTRONIK SE & Co KG, Boston Scientific Corporation, Concordia Laboratories Inc., Edwards Lifesciences Corporation, Eurosets S.r.l, Fresenius Medical Care AG, General Electric Company, Getinge AB, Jarvik Heart, Inc., Johnson & Johnson, LivaNova PLC, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Penumbra, Inc., Senko Medical Instrument Manufacturing Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Spectrum Medical, Stryker Corporation, SynCardia Systems, LLC, and Terumo Corporation. Strategic Recommendations for Market Leadership

Industry leaders are encouraged to capitalize on the rapid evolution of technology and the increasing demand for customized solutions in the cardiopulmonary support landscape. A key recommendation is to invest strategically in research and development initiatives that not only enhance current product lines but also explore emerging areas like artificial intelligence and real-time data analytics. Leveraging digital transformation can facilitate better integration of devices, providing a unified interface that enhances decision-making processes in complex clinical settings.

Moreover, building strategic alliances with academic institutions and research organizations can offer fresh perspectives and provide access to breakthrough technologies. Industry players should also focus on expanding their global footprint by tailoring solutions to meet local regulatory requirements, thereby fostering trust among healthcare providers. Continuous education and training programs for clinicians should be prioritized to ensure the proficient use of sophisticated support systems, ultimately driving improved patient outcomes.

A proactive approach towards understanding demographic trends and the shifting disease burden will prove essential. Leaders are advised to undertake comprehensive market research to pinpoint evolving patterns in patient types and disease conditions, ensuring timely alignment of product portfolios with growing clinical needs. Such a multifaceted strategy, grounded in innovation and collaboration, can drive sustained growth and secure a competitive edge in an increasingly complex and dynamic market environment.

Final Remarks and Strategic Outlook

In summary, the cardiopulmonary support system market is poised for unprecedented growth as advancements in technology and evolving clinical practices redefine the benchmarks of patient care. This report has detailed not only current market trends but also the multitude of segmentation insights that reveal deep structural changes within the industry. The shift towards integrated solutions and data-driven decision-making continues to provide avenues for enhanced safety, efficiency, and patient outcomes.

Looking ahead, it is evident that continued innovation, coupled with strategic collaborations, will serve as the cornerstone for future success. Stakeholders across the spectrum-from product developers and clinical researchers to healthcare providers and strategic investors-stand to benefit from embracing these advancements. This dynamic market landscape represents both challenges and significant opportunities for those poised to lead the charge in redefining critical care solutions.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of cardiopulmonary diseases globally
    • 5.1.1.2. Rising awareness and accessibility of treatment options
    • 5.1.1.3. Government incentives and funding encouraging innovation in cardiopulmonary support technology
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of cardiopulmonary support systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing adoption of artificial intelligence in enhancing precision and efficiency
    • 5.1.3.2. Increasing preference for portable and compact cardiopulmonary support systems
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory compliance requirements for cardiopulmonary support devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Increasing preference for cardiopulmonary bypass equipment in open-heart surgeries
  • 5.2.2. Application: Expanding application of cardiopulmonary support systems in cardiac surgery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiopulmonary Support System Market, by Component

• 6.1. Introduction
• 6.2. Cardiopulmonary Bypass Equipment
• 6.3. Extracorporeal Membrane Oxygenation
• 6.4. Intra-Aortic Balloon Pumps
• 6.5. Ventricular Assist Devices

7. Cardiopulmonary Support System Market, by Disease Type

• 7.1. Introduction
• 7.2. Adult Respiratory Distress Syndrome
• 7.3. Cardiogenic Shock
• 7.4. Pulmonary Edema

8. Cardiopulmonary Support System Market, by Patient Type

• 8.1. Introduction
• 8.2. Adult Patients
• 8.3. Geriatric
  • 8.3.1. Patients
• 8.4. Pediatric Patients

9. Cardiopulmonary Support System Market, by Application

• 9.1. Introduction
• 9.2. Cardiac Surgery
• 9.3. Cardiology
• 9.4. Emergency Medicine
• 9.5. Intensive Care

10. Cardiopulmonary Support System Market, by End Use

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Specialty Clinics

11. Americas Cardiopulmonary Support System Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Cardiopulmonary Support System Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Cardiopulmonary Support System Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Corify Care's EUR 6 million funding amplifies non-invasive cardiac mapping innovation
  • 14.3.2. Medtronic innovates cardiopulmonary care with the launch of the user-friendly VitalFlow ECMO system
  • 14.3.3. NuvoAir and Privia Medical Group collaborate to enhance cardiopulmonary care with virtual-first model
  • 14.3.4. ADI launches FDA-approved Sensinel System for remote monitoring
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Baxter International
• 3. BIOTRONIK SE & Co KG
• 4. Boston Scientific Corporation
• 5. Concordia Laboratories Inc.
• 6. Edwards Lifesciences Corporation
• 7. Eurosets S.r.l
• 8. Fresenius Medical Care AG
• 9. General Electric Company
• 10. Getinge AB
• 11. Jarvik Heart, Inc.
• 12. Johnson & Johnson
• 13. LivaNova PLC
• 14. Medtronic PLC
• 15. MicroPort Scientific Corporation
• 16. Nipro Corporation
• 17. Penumbra, Inc.
• 18. Senko Medical Instrument Manufacturing Co., Ltd.
• 19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 20. Siemens AG
• 21. Spectrum Medical
• 22. Stryker Corporation
• 23. SynCardia Systems, LLC
• 24. Terumo Corporation